MedTrace Logo

Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients

NCT05279586 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 316

Last updated 2022-03-15

No results posted yet for this study

Summary

The aim of this study is to compare the efficacy and safety of colistin versus lactulose for secondary prophylaxis of overt hepatic encephalopathy in patients with liver cirrhosis.

Conditions

  • Hepatic Encephalopathy

Interventions

DRUG

lactulose

all interventions are used in secondary prophylaxis in cirrhotic patients

DRUG

colistin

all interventions are used in secondary prophylaxis in cirrhotic patients

Sponsors & Collaborators

  • Madonna Magdy Fahmy

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2023-02-28
Completion
2023-03-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05279586 on ClinicalTrials.gov